Effect of CD4+T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer

by on 24 d'octubre de 2022 with No hi ha comentaris
  • Odeny, T. A., Lurain, K., Strauss, J., Fling, S. P., Sharon, E., Wright, A., . . .Martinez-Picado, J., … Ramaswami, R. (2022). Effect of CD4+T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer. Journal for Immunotherapy of Cancer, 10(9), Article e005128. https://doi.org/10.1136/jitc-2022-005128

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *